江湖电竞投注
BAYN
XE
0.96
1.85%
Closed
€ 52.87
| Previous Close |
|---|
| €51.91 |
Volume: 2.32M
65 Day Avg: 2.89M
52.25
Day Range
53.28
43.91
52 Week Range
67.99
Overview
BAYN Overview
Key Data
- Open €52.31
- Day Range 52.25 - 53.28
- 52 Week Range 43.91 - 67.99
- Market Cap €51B
- Shares Outstanding 982.42M
- Public Float N/A
- Beta 0.98
- Rev. per Employee €485.33K
- P/E Ratio 12.25
- EPS €4.31
- Yield 3.78%
- Dividend €2.00
- Ex-Dividend Date May 2, 2022
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 2.89M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings
20
Full Ratings
Recent News
Idaho farmers file antitrust lawsuit against big ag companies
A group of farmers has filed an antitrust case against several big agricultural companies, contending the companies worked together to ban e-commerce sales in order to keep prices artificially high.
Novartis agrees to help make CureVac COVID-19 vaccine
Novartis AG and CureVac NV said Thursday they have reached an agreement for Novartis to help CureVac manufacture its COVID-19 vaccine, which is currently under review by the European Medicines Agency. Novartis expects to...
Bayer AG
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Novartis AG |
|
CHF172.8B |
| Roche Holding AG Akt |
|
CHF266.05B |
| Sanofi S.A. |
|
€101.44B |
| Eli Lilly & Co. |
|
CHF295.72B |
| Merck & Co. Inc. |
|
€221.21B |
| Pfizer Inc. |
|
kr2.84T |